Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

615 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons.
Antinori A, Marcotullio S, Ammassari A, Andreoni M, Angarano G, Carosi G, Cinque P, d'Arminio Monforte A, Di Perri G, Ensoli B, Ferrazzi E, Galli M, Mastroianni C, Matteelli A, Mazzotta F, Moroni M, Palù G, Puoti M, Puro V, Rizzardini G, Sagnelli E, Suter F, Vella S, Lazzarin A; Italian HIV Guidelines Working Group. Antinori A, et al. Among authors: palu g. New Microbiol. 2011 Apr;34(2):109-46. Epub 2011 Apr 30. New Microbiol. 2011. PMID: 21617825 Free article. No abstract available.
Nevirapine use, prolonged antiretroviral therapy and high CD4 nadir values are strongly correlated with undetectable HIV-DNA and -RNA levels and CD4 cell gain.
Sarmati L, Parisi SG, Montano M, Andreis S, Scaggiante R, Galgani A, Viscione M, Maffongelli G, Ricciardi A, Andreoni C, Boros S, Palù G, Andreoni M. Sarmati L, et al. Among authors: palu g. J Antimicrob Chemother. 2012 Dec;67(12):2932-8. doi: 10.1093/jac/dks331. Epub 2012 Aug 21. J Antimicrob Chemother. 2012. PMID: 22915460 Clinical Trial.
Structural equation modelling of viral tropism reveals its impact on achieving viral suppression within 6 months in treatment-naive HIV-1-infected patients after combination antiretroviral therapy.
Mengoli C, Andreis S, Scaggiante R, Cruciani M, Bosco O, Ferretto R, Leoni D, Maffongelli G, Basso M, Torti C, Sarmati L, Andreoni M, Palù G, Parisi SG. Mengoli C, et al. Among authors: palu g. J Antimicrob Chemother. 2017 Jan;72(1):220-226. doi: 10.1093/jac/dkw348. Epub 2016 Sep 7. J Antimicrob Chemother. 2017. PMID: 27605599
Time course of cellular HIV-DNA and low-level HIV viremia in HIV-HCV co-infected patients whose HCV infection had been successfully treated with directly acting antivirals.
Parisi SG, Andreis S, Basso M, Cavinato S, Scaggiante R, Franzetti M, Andreoni M, Palù G, Cattelan AM. Parisi SG, et al. Among authors: palu g. Med Microbiol Immunol. 2017 Dec;206(6):419-428. doi: 10.1007/s00430-017-0518-x. Epub 2017 Sep 1. Med Microbiol Immunol. 2017. PMID: 28864951
Association between cellular human immunodeficiency virus DNA level and immunological parameters in patients with undetectable plasma viremia level during highly active antiretroviral therapy.
Sarmati L, Parisi SG, Nicastri E, d'Ettorre G, Palmisano L, Andreotti M, Andreoni C, Giuliano M, Gatti F, Boldrin C, Palù G, Vullo V, Vella S, Andreoni M. Sarmati L, et al. Among authors: palu g. J Clin Microbiol. 2005 Dec;43(12):6183-5. doi: 10.1128/JCM.43.12.6183-6185.2005. J Clin Microbiol. 2005. PMID: 16333125 Free PMC article.
Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1-HCV co-infected patients on effective combined anti-HIV treatment.
Parisi SG, Andreis S, Mengoli C, Menegotto N, Cavinato S, Scaggiante R, Andreoni M, Palù G, Basso M, Cattelan AM. Parisi SG, et al. Among authors: palu g. Med Microbiol Immunol. 2018 Aug;207(3-4):183-194. doi: 10.1007/s00430-018-0538-1. Epub 2018 Mar 9. Med Microbiol Immunol. 2018. PMID: 29523966
Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usage.
Svicher V, Alteri C, Artese A, Zhang JM, Costa G, Mercurio F, D'Arrigo R, Alcaro S, Palù G, Clementi M, Zazzi M, Andreoni M, Antinori A, Lazzarin A, Ceccherini-Silberstein F, Perno CF; OSCAR study group. Svicher V, et al. Among authors: palu g. Antivir Ther. 2011;16(7):1035-45. doi: 10.3851/IMP1862. Antivir Ther. 2011. PMID: 22024519
Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013-2016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitors.
Andreis S, Basso M, Scaggiante R, Cruciani M, Ferretto R, Manfrin V, Panese S, Rossi MC, Francavilla E, Boldrin C, Alvarez M, Dal Bello F, Mengoli C, Turriziani O, Sarmati L, Antonelli G, Andreoni M, Palù G, Parisi SG. Andreis S, et al. Among authors: palu g. J Glob Antimicrob Resist. 2017 Sep;10:106-112. doi: 10.1016/j.jgar.2017.05.011. Epub 2017 Jul 18. J Glob Antimicrob Resist. 2017. PMID: 28732792
Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach.
Mengoli C, Basso M, Andreis S, Scaggiante R, Cruciani M, Ferretto R, Panese S, Manfrin V, Francisci D, Schiaroli E, Maffongelli G, Sarmati L, Andreoni M, Baldelli F, Palu' G, Parisi SG. Mengoli C, et al. Among authors: palu g. PLoS One. 2019 Mar 11;14(3):e0213160. doi: 10.1371/journal.pone.0213160. eCollection 2019. PLoS One. 2019. PMID: 30856186 Free PMC article.
615 results